Trinity Biotech plc announced the promotion of John Gillard, Chief Financial Officer, to Chief Executive Officer, effective immediately. Mr. Gillard has served as Chief Financial Officer and board member of the company since November 2020. He is an experienced international business executive, having held senior roles at Google, SSE plc and ION Investment Group.

Mr. Gillard is a Chartered Accountant having trained at PWC. Mr. Gillard succeeds Aris Kekedjian, who is resigning as Chief Executive Officer effective 17 December 2023.